The Cardiac Biomarkers Market is Expected to be Flourished by Adoption of Point-of-Care Testing
![]() |
Cardiac Biomarkers Market |
Cardiac
biomarkers are proteins that are released into the blood when the heart muscle
is stressed. They play a vital role in the diagnosis and management of acute
coronary syndromes and myocardial infarction. Common cardiac biomarkers include
troponin, CK-MB, myoglobin, BNP, and others. The cardiac biomarkers market has
witnessed significant growth in recent times due to the increasing prevalence
of cardiovascular diseases and growing adoption of point-of-care testing.
Point-of-care testing delivers test results quicker and allows for fast
clinical decision making. It is widely adopted in hospitals, diagnostic
laboratories, and other healthcare settings for rapid diagnosis of heart
attacks.
The
global cardiac biomarkers market is estimated to be valued at US$ 9836.55 in
2023 and is expected to exhibit a CAGR of 6.0% over the forecast period 2023 to
2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: One of the key drivers for the growth of the cardiac
biomarkers market is the increasing adoption of point-of-care testing. Point-of-care
testing offers immediate diagnosis of cardiovascular conditions without the
need for centralized laboratories. It provides test results in less than 30
minutes compared to several hours taken by other conventional laboratory
methods. This enables critical clinical decision making and early intervention.
Moreover, it is convenient for patients as it does away with transportation
time to a diagnostic laboratory. Faster diagnostic information with
point-of-care testing helps in improving patient outcomes in acute care
settings.
Segment Analysis
The global Cardiac Biomarkers market is dominated by the diagnostic segment
which holds more than 85% share. Within diagnostics, the cardiac troponins
(cTn) sub-segment leads with over 70% share owing to their high sensitivity and
cardiac specificity. The cTn biomarkers help in early detection of myocardial
injury and have replaced myoglobin and CK-MB for diagnosing myocardial
infarction as per the new guidelines.
PEST Analysis
Political: The market is favourbale impacted by initiatives taken by various
governments and regulatory bodies to spread awareness about heart diseases and
enhance diagnostics.
Economic: Rising geriatric population and increasing healthcare spending on
cardiology indicate long term groth prospects for biomarkers.
Social: Growing burden of cardiac conditions and rising demand for minimally
invasive testing is driving increased adoption of biomarkers.
Technological: Advancements in assay sensitivity have enabled earlier detection
of myocardial injury. Miniaturization of platforms aid point-of-care testing.
Key Takeaways
The Global
Cardiac Biomarkers Market Share is expected to witness high growth at a
CAGR of 6.0% during the forecast period of 2023 to 2030.
Regionally,
North America dominated with over 40% market share in 2024 led by US on back of
advanced healthcare facilities and high diagnostic rate for cardiac diseases.
Asia Pacific is expected to be the fastest growing region due to rising
awareness, healthcare investments and growing disease prevalence in countries
like China and India.
Key players operating in the cardiac biomarkers market are Abbott Laboratories,
F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories,
Inc., Danaher Corporation, Randox Laboratories Ltd., Siemens Healthineers, and
BioMérieux SA. Abbott holds the largest share owing to its robust product
portfolio of analyzer systems and reagents for high, mid and low throughput
settings. Roche and Siemens are other major players focusing on assays for
myoglobin, CK-MB and high sensitivity and specificity troponin tests.
For
more details on the report, Read- https://www.pressreleasebulletin.com/cardiac-biomarkers-market-trends-size-and-share-analysis/
Explore more trending article on this topic: https://www.shayaricenter.com/natures-barcodes-biomarkers-illuminate-paths-to-wellness-and-scientific-breakthroughs
Comments
Post a Comment